Chronic treatment with a serotonin2 receptor (5-HT2R) agonist modulates the behavioral and cellular response to (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA]

Authors:
  • DHDavid V. Herin
    David V. Herin
  • PFPaul S. Frankel
    Paul S. Frankel
  • MTMary L. Thomas
    Mary L. Thomas
  • KCKathryn A. Cunningham
    Kathryn A. Cunningham

Abstract
No abstract available

This publication has 57 references indexed in Scilit: